Agfa to acquire EU contrast developer for nearly $15M

Agfa HealthCare, a provider of diagnostic imaging and health IT solutions, has signed an agreement with Curagita Holding to acquire all the shares of its subsidiary Insight Agents, a European developer of contrast media, with business activities mainly in Germany.

The final acquisition price is expected to be around EUR10 million ($14.97 million U.S.).

According to Agfa, contrast media are primarily used with x-rays, CT scans and MRI, either to highlight anatomical structures (mostly vessels) or to perform functional imaging. “The decision to purchase a new line of business was made to ensure that we continue to offer a range of diagnostic imaging products over which we have full control,” said Dirk Debusscher, vice president of imaging at Agfa.

The companies said they are working “diligently” to close the transaction by the end of 2009.